Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.20.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2020
Stockholders’ Equity  
Common Stock Warrants Outstanding

 

 

 

 

    

Common Stock 

 

 

Warrants

Outstanding, December 31, 2019

 

9,030,730

Issued

 

10,000,000

Exercised

 

(9,960,000)

Exchanged

 

(3,291,666)

Outstanding, March 31, 2020

 

5,779,064

 

Schedule of Stock Option Valuation Assumptions

 

 

 

 

 

 

 

 

    

2020

 

 

2019

 

Dividend yield

 

 —

%  

 

 —

%

Expected volatility

 

89.61

%  

 

131.10

%

Risk-free interest rate

 

0.86

%  

 

2.50

%

Expected lives (years)

 

5.9

years

 

5.5

years

 

Schedule of Stock Option Activity

 

 

 

 

 

 

 

 

 

 

 

    

 

    

Weighted

 

Weighted

 

 

 

 

Average

 

Average

 

 

 

 

Exercise

 

Remaining

 

 

Shares

 

Price

 

Contractual Life

Stock options outstanding at December 31, 2019

 

3,063,636

 

$

2.56

 

 

 

Granted

 

2,567,000

 

 

0.58

 

 

 

Forfeited/Expired

 

(35,076)

 

 

2.35

 

 

 

Stock options outstanding at March 31, 2020

 

5,595,560

 

$

1.65

 

9.1

Years

Stock options exercisable at March 31, 2020

 

2,198,387

 

$

2.95

 

8.4

Years

 

Schedule of Unvested Restricted Stock Activity

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Shares

 

Fair Value

Restricted stock at December 31, 2019

 

1,254,653

 

$

0.86

Granted

 

2,380,000

 

 

0.46

Vested

 

(1,622,720)

 

 

0.62

Restricted stock at March 31, 2020

 

2,011,933

 

$

0.58

 

Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Shares

 

Fair Value

RSUs at December 31, 2019

 

30,026

 

$

4.33

Vested

 

(16,406)

 

 

4.73

Cancelled

 

(338)

 

 

5.20

RSUs at March 31, 2020

 

13,282

 

$

3.80